Sub-340B Price (PVP)
Definition
Sub-340B pricing represents contracted prices that are below the statutory 340B ceiling price, negotiated by Apexus with drug manufacturers on behalf of PVP participants. These prices are available to covered entities that participate in the PVP and represent an additional layer of savings beyond what the 340B statute requires.
Sub-340B prices are negotiated through individual contracts between the manufacturer and each covered entity at the 340B ID level, which makes them compliant with the GPO Prohibition for applicable hospital types. The prices are loaded in the covered entity’s 340B purchasing account.
Not all drugs have sub-340B pricing available. The availability of sub-340B prices depends on manufacturer participation in PVP contracting. Covered entities should monitor which drugs in their formulary have sub-340B pricing available and ensure their purchasing systems are configured to access these prices.
Frequently Asked Questions
Why Sub-340B Price (PVP) Matters
Sub-340B pricing provides additional savings beyond the statutory ceiling price. Covered entities that are not accessing available sub-340B prices may be leaving savings unrealized. For high-volume drugs with sub-340B pricing, the additional savings can be significant.
How Virtue 340B Uses It
Virtue 340B helps covered entities identify and access sub-340B pricing opportunities as part of our program optimization services.